Table II.
Patient number | Arm | Symptoms | Indication for testing | NEWS Day | Ct Day | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0 | 3 | 7 | 10 | 0 | 3 | 7 | 10 | ||||
5 | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | UD | UD | UD | UD |
8 | Control | Fever, sore throat ×12 days | Symptomatic | 1 | 1 | 0 | 0 | UD | 35.2 | UD | UD |
11 | Control | Nil | Contact tracing | 0 | 0 | 0 | 0 | 37.3 | UD | 32.8 | 37.4 |
16 | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | UD | 35.9 | 34 | UD |
19 | Control | Chest discomfort, fever ×10 days | Symptomatic, Healthcare worker | 0 | 0 | 0 | 1 | 36.2 | 36.6 | 37.2 | UD |
21 | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | 35 | UD | UD | UD |
22 | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | 40 | UD | UD | 34.8 |
23 | Control | Nil | Contact tracing | 0 | 0 | 0 | 0 | 35.7 | 35.1 | 32.6 | 30.4 |
31 | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | 37.6 | 35.1 | UD | UD |
58* | Nasal CQN | Nil | Contact tracing | 0 | 0 | 0 | 0 | UD | UD | 37 | 34.5 |
59 | Control | Nil | Contact tracing | 0 | 0 | 0 | 0 | 36.7 | 25.8 | UD | 34.9 |
*Poor compliance-did not use the drug after first dose instillation. Ct, cycle threshold; UD, undetected